Literature DB >> 1562456

Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression.

M F Gartner1, C Fearns, E L Wilson, J A Campbell, E B Dowdle.   

Abstract

When human melanoma cells are injected into nude mice they usually give rise to tumours that grow progressively and do not elicit a prominent host response. We have recently developed a melanoma cell line, UCT-Mel 7, that did not show these characteristics. In the first place UCT-Mel 7 showed a consistently unusual, phasic growth pattern. After a short initial period of limited growth (phase 1), the tumour ceased growing and remained static for 2-3 months (phase 2). The tumour then regressed (phase 3) to enter a second period of quiescence (phase 4) which was eventually broken by the emergence of a rapidly growing lethal tumour (phase 5). Of particular interest was the fact that the rate at which the tumours grew correlated closely with their collagen content. During the prolonged, phase 2 plateau, the tumours were intensely desmoplastic; rapidly growing phase 5 tumours, that had escaped from dormancy, contained very little collagen and virtually no reticulin. This cell line helps to fill an important need for an experimental system for the study of desmoplasia, dormancy and progression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562456      PMCID: PMC1977579          DOI: 10.1038/bjc.1992.101

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  A Simple Method for the Silver Impregnation of Reticulum.

Authors:  H Gordon; H H Sweets
Journal:  Am J Pathol       Date:  1936-07       Impact factor: 4.307

Review 2.  Fibroblast growth factor: structural and biological properties.

Authors:  D Gospodarowicz
Journal:  Int J Rad Appl Instrum B       Date:  1987

3.  Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis.

Authors:  R Roberts; J Gallagher; E Spooncer; T D Allen; F Bloomfield; T M Dexter
Journal:  Nature       Date:  1988-03-24       Impact factor: 49.962

4.  Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta.

Authors:  R A Ignotz; T Endo; J Massagué
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

Review 5.  Mechanisms of tumor progression.

Authors:  P C Nowell
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

6.  Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.

Authors:  R Raghow; A E Postlethwaite; J Keski-Oja; H L Moses; A H Kang
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

7.  N:NIH(S)-nu/nu mice with combined immunodeficiency: a new model for human tumor heterotransplantation.

Authors:  H A Azar; C T Hansen; J Costa
Journal:  J Natl Cancer Inst       Date:  1980-08       Impact factor: 13.506

8.  Desmoplastic diffuse mesothelioma.

Authors:  R Cantin; M Al-Jabi; W T McCaughey
Journal:  Am J Surg Pathol       Date:  1982-04       Impact factor: 6.394

9.  bFGF as an autocrine growth factor for human melanomas.

Authors:  R Halaban; B S Kwon; S Ghosh; P Delli Bovi; A Baird
Journal:  Oncogene Res       Date:  1988-09

10.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.

Authors:  O Saksela; D Moscatelli; A Sommer; D B Rifkin
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

View more
  3 in total

1.  Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.

Authors:  R Demicheli; A Abbattista; R Miceli; P Valagussa; G Bonadonna
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Micro-environmental mechanical stress controls tumor spheroid size and morphology by suppressing proliferation and inducing apoptosis in cancer cells.

Authors:  Gang Cheng; Janet Tse; Rakesh K Jain; Lance L Munn
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

3.  Metastatic tumor dormancy in cutaneous melanoma: does surgery induce escape?

Authors:  William W Tseng; Niloofar Fadaki; Stanley P Leong
Journal:  Cancers (Basel)       Date:  2011-02-21       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.